Study Stopped
budget
Contraceptive Pathway and Contraception Continuation Rates
Impact of a Contraceptive Pathway on Contraception Continuation Rates
1 other identifier
interventional
400
1 country
1
Brief Summary
Women seeking contraception will be randomized to "usual care" or to a "Contraceptive Pathway"
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 26, 2019
CompletedFirst Posted
Study publicly available on registry
April 23, 2019
CompletedStudy Start
First participant enrolled
January 3, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2024
CompletedMay 6, 2022
May 1, 2022
1.4 years
March 26, 2019
May 2, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Continued Use of Contraception at 1 year
The difference in contraception continuation rates will be compared between the Contraceptive Pathway group and the Usual care group, based on follow up phone calls at 3 weeks, 6 months and 1 year
1 year
Secondary Outcomes (2)
Subject satisfaction with contraceptive counseling
at initial office visit/immediate
Pregnancy rates
1 year
Study Arms (2)
usual care
NO INTERVENTIONwomen who present for birth control to the gynecology office will see their physician in the usual fashion for review, counseling and contraception decision/initiation. Follow up phone call will be done at 2 weeks, 3, 6 and 12 months to discuss contraception initiation and continuation.
Contraceptive pathway
EXPERIMENTALWomen who present for birth control to the gynecology office will be recognized by the front desk and offered a tablet which which will: 1. collect relevant medical history 2. provide educational material on birth control options 3. provide a link to bedsider.com for further information They will then discuss the tablet information/history with the medical assistant, who will answer any remaining questions. They will then see the physician/APN. Follow up phone call will be done at 2 weeks, 3, 6 and 12 months to discuss contraception initiation and continuation.
Interventions
alternative way of aiding patients in deciding contraception method
Eligibility Criteria
You may qualify if:
- Women at risk for pregnancy
- Women able to read and write in English
You may not qualify if:
- Women who have undergone permanent sterilization
- Women not sexually active with a male partner
- Women who intend to become pregnant in the next 12 months
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Rutgers, The State University of New Jerseylead
- Bayercollaborator
Study Sites (1)
Clinical Academic Building. 125 Paterson Street
New Brunswick, New Jersey, 08901, United States
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Adrian C Balica, MD
Rutgers Robert Wood Johnson Medical School
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor, Dept. Ob/Gyn, RWJMS
Study Record Dates
First Submitted
March 26, 2019
First Posted
April 23, 2019
Study Start
January 3, 2023
Primary Completion
June 1, 2024
Study Completion
June 1, 2024
Last Updated
May 6, 2022
Record last verified: 2022-05
Data Sharing
- IPD Sharing
- Will not share